BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

  Longboard Pharmaceuticals, Inc. announced that it will host a conference call to discuss topline data from the PACIFIC Study, a Phase 1b/2a clinical trial evaluating bexicaserin in participants with a broad range of Developmental and Epileptic Encephalopathies.

  January 1, 2024

   · 

  7 min read
• Drug Development

  Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity

  Innovent Biologics, Inc. announces that the first participant has been successfully dosed in a Phase 3 clinical trial of higher dose 9 mg mazdutide, a glucagon-like peptide 1 receptor and glucagon receptor dual agonist, in Chinese adults with obesity.

  January 1, 2024

   · 

  8 min read
• BioCapital

  Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference

  Ascentage Pharma announced that it will attend the 42nd J.P. Morgan Healthcare Conference, and Dr. Dajun Yang, its Chairman and CEO, will give a presentation on Ascentage Pharma at the conference at 2:00 AM, Thursday, January 11, 2024, Beijing Time.

  January 1, 2024

   · 

  4 min read